Techammer
Techammer is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Techammer.
Techammer is a company.
Key people at Techammer.
Techammer is an angel investment group formed by married partners Jeff Hammerbacher and Halle Tecco, operating as LPs and direct angel investors focused on seed-stage startups.[1][2][3][4] Their mission centers on empowering founders tackling meaningful problems in data science, digital health, and companies accelerating scientific progress, with particular excitement for ventures improving everyday Americans' lives.[1][2][3][4] Key sectors include electronics & advanced materials, food & agriculture, information technology, life sciences & healthcare, digital, edtech, healthcare services, and robotics.[1][5] In the startup ecosystem, Techammer leverages the partners' deep expertise—Hammerbacher from Cloudera and Facebook, Tecco from Rock Health and Natalist—to provide hands-on support, evidenced by investments in high-profile exits like Aardvark (Google) and Kaggle (Google), and ongoing portfolio companies such as Astranis, Brightside Health, and Viz.ai.[3]
Techammer traces its roots to 2007, when Jeff Hammerbacher and Halle Tecco met in San Francisco.[2][3] Both Midwest-raised—Jeff from Michigan/Indiana and Halle from Ohio, starting careers bagging groceries—they built illustrious paths in tech and health before uniting as investors.[2] Hammerbacher, a Harvard math graduate, founded Cloudera as Chief Scientist, worked as a scientist at Hammer Lab, and held roles at Facebook and Bear Stearns; he now serves on boards like Datavant and PerkinElmer.[2] Tecco, with an MPH from Johns Hopkins, MBA from Harvard Business School, and BS from Case Western, co-founded Rock Health and Natalist (acquired by Everly Health), co-hosts The Heart of Healthcare podcast, and teaches at Columbia Business School and Harvard Medical School; she's on boards including Cofertility and Collective Health.[2] Married in Italy in 2012 after nine San Francisco years, they relocated to NYC and formalized Techammer to channel their angel investing into focused sectors, evolving from individual efforts to a joint vehicle supporting science-driven founders.[2][3][4]
Techammer rides the convergence of AI-driven data science, digital health expansion post-COVID, and accelerated scientific computing, trends exploding with generative AI and precision medicine demands.[1][2] Timing is ideal amid 2025's biotech funding resurgence and compute shortages, where their "make science go faster" thesis aligns with market forces like talent shortages in deep tech and underserved U.S. health access.[1][3] They influence the ecosystem by backing outliers—like Viz.ai's FDA-cleared stroke AI or Astranis' satellite tech—that scale national impact, while partners' networks (e.g., Harvard/Columbia ties) bridge Silicon Valley to Midwest innovation, democratizing capital for meaningful, America-focused problems.[2][3]
Techammer's intimate model positions it to thrive in a consolidating VC landscape, doubling down on AI-health intersections and scientific tools amid 2026+ regulatory tailwinds for digital therapeutics.[3] Expect deeper portfolio plays in robotics/health AI, potential fundraises leveraging exits, and expanded influence via Tecco's podcast and Hammerbacher's data legacy—shaping how seed capital fuels 2-3x returns in impact-driven tech. This duo's origin—from grocery bags to Google acquisitions—exemplifies how personal grit humanizes high-stakes investing, promising sustained ecosystem uplift.[2][3]
Key people at Techammer.